Antibiotics that doctors typically prescribe for sinus infections works no better than a dummy pill in getting rid of the ailment, according to a study to be published Wednesday in the Journal of the American Medical Association. The study included 166 adults whose symptoms fit the criteria for acute sinus infection. They were randomly assigned to receive a 10-day course of either amoxicillin or placebo. Three days after starting antibiotics, there were little difference in symptoms between those taking amoxicillin and those given a placebo. At day seven, a small improvement was seen in the antibiotic group's questionnaire scores. This modest statistical improvement disappeared by day 10, when about 80 percent of patients in both groups reported their symptoms were very much improved or cured. "Patients don't get better faster or have fewer symptoms when they get antibiotics," says Jay Piccirillo, professor of otolaryngology at Washington University School of Medicine in St. Louis and the study's senior author. "Our results show that antibiotics aren't necessary for a basic sinus infection -- most people get better on their own." In the United States as many as one in five antibiotic prescriptions are for sinus infections, the authors point out. And given the rise of bacteria resistant to such drugs, they say it is important to find out whether this treatment is effective. Their results show it is not.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor